Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × NETWORK × Other solid neoplasm × Clear all

Phase

Phase 1 24 Phase 2 11 Phase NA 5 Phase 3 3 Phase 1/2 2 Phase 2/3 1

Status

Sponsor Class

OTHER 6 INDUSTRY 4 OTHER_GOV 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 7 Gastrointestinal 5 Other hematologic neoplasm 3 Lymphoid 3 Sarcoma 2 Genitourinary 2 Plasma cell 1 Other solid neoplasm 1 Head & Neck 1 Gynecologic 1 Dermatologic 1 CNS 1 Breast 1

Conditions

Interventions

pembrolizumab 1 Pemetrexed 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02784171 2024-12-10

Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma

Canadian Cancer Trials Group

Phase 2/3 Completed

520 enrolled 16 charts 1 FDA

Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡